What is Denali Therapeutics (DNLI)?
Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for neurodegenerative diseases. The company employs a multidisciplinary approach combining genetics, biology, and drug development to address conditions such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis. Denali Therapeutics utilizes advanced research platforms and proprietary technologies to identify novel therapeutic targets and develop biologics and small molecules. The company's pipeline includes multiple candidates aimed at modifying disease progression. Denali collaborates with academic institutions and industry partners to advance its research and bring potential treatments to patients.
Denali Therapeutics Stock Price Today: Live Overview
The price today is shaped by intraday market movements, with Denali Therapeutics trading at $19.55. It has experienced a range from $18.91 up to $19.94, with a daily change percentage of -2.6513%.
FAQ: Denali Therapeutics (DNLI)
What is the current price of DNLI stock?
Denali Therapeutics is trading at $19.55.
Does DNLI pay dividends?
Denali Therapeutics does not pay dividends.
Does DNLI have a formal corporate presence or regional headquarters in the UAE?
Denali Therapeutics does not have an official office or subsidiary in the UAE and operates via partners or distributors.
What is DNLI best known for?
Denali Therapeutics is most famous for its work in neurodegenerative disease therapies.
What assets are typically shown together with DNLI?
Commonly shown alongside DNLI: Above Food Ingredients Inc, ProShares Ultra SmallCap600, Cassava Sciences Inc
Latest shares articles



